药康生物:收入稳步增长,费用投放加大等因素致利润承压
GemPharmatech (688046) 华安证券·2024-11-05 00:41
[Table_Profit] 药康生物( [Table_StockNameRptType] 688046) | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...